Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. ApoB and apoM - New aspects of lipoprotein biology in uremia-induced atherosclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Paolo Fagone
  • Emanuela Mazzon
  • Placido Bramanti
  • Klaus Bendtzen
  • Ferdinando Nicoletti
View graph of relations

Gasotransmitters are a group of gaseous molecules, with pleiotropic biological functions. These molecules include nitric oxide (NO), hydrogen sulfide (H2S), and carbon monoxide (CO). Abnormal production and metabolism of these molecules have been observed in several pathological conditions. The understanding of the role of gasotransmitters in the immune system has grown significantly in the past years, and independent studies have shed light on the effect of exogenous and endogenous gasotransmitters on immune responses. Moreover, encouraging results come from the efficacy of NO-, CO- and H2S -donors in preclinical animal models of autoimmune, acute and chronic inflammatory diseases. To date, data on the influence of gasotransmitters in immunity and immunopathology are often scattered and partial, and the scarcity of clinical trials using NO-, CO- and H2S -donors, reveals that more effort is warranted. This review focuses on the role of gasotransmitters in the immune system and covers the evidences on the possible use of gasotransmitters for the treatment of inflammatory conditions.

Original languageEnglish
JournalEuropean Journal of Pharmacology
Volume834
Pages (from-to)92-102
Number of pages11
ISSN0014-2999
DOIs
Publication statusPublished - 5 Sep 2018

    Research areas

  • Animals, Gasotransmitters/metabolism, Humans, Immune System/drug effects, Molecular Targeted Therapy/methods

ID: 56669389